Fuji Pharma Valley Initiatives

Text sizesmallmediumlarge

  • Pharma Valley Center
  • Shizuoka Highlights

ここから本文です。

HOME > Strategy 1 Building a Health Infrastructure > Developing advanced drugs through clinical trials and improving the quality of medical care

Strategy 1 Building a Health Infrastructure R&D from the perspective of patients and the people of the prefecture

Developing advanced drugs through clinical trials and improving the quality of medical care

In order to promote and disseminate advanced drugs and improve the quality of medical care, we are enhancing the scope of the Fuji-Clinical Trial Study Group. We are also pursuing international cooperative clinical trials.

network

Enhancing the scope of the Fuji-Clinical Trial Study Group(29 hospitals, approximately 14,000 beds)

  • Clinical trial results (cumulative total from 2003 to 2006)
    Number of trustee agreements: 29
    Number of agreement implementation cases: 405

Increasing the competence of clinical trial personnel

Pursuing international cooperative clinical trials

Back to top